A Patient with ALL Underwent Chemotherapy

Multiple Choice

A patient with ALL underwent chemotherapy. Results from hematologic, cytogenetic, and molecular analyses indicated that the patient entered complete remission. Four years later, on routine follow-up, the peripheral blood results for the patient were in the normal range, and cytogenetic analysis revealed no abnormalities, but molecular analysis showed BCR/ABL1 transcripts that were found in the blasts at diagnosis 4 years ago. This patient can be said to:

A) Be in complete remission
B) Be in molecular and cytogenetic remission
C) Have minimal residual disease
D) Have partial cytogenetic remission